Bioline Rx Ltd (BLRX)

• $0.61

  $0.64

  $0.61
  

  0.82%

  Downside

  Day's Volatility :5.42%

  Upside

  4.64%

  
• $0.51

  $2.33

  $0.61
  

  16.39%

  Downside

  52 Weeks Volatility :78.11%

  Upside

  73.82%

  

Returns

What analysts predicted

Upside of 1511.48%

• Alyeska Investment Group, L.P.

  2.44%

• CVI Holdings LLC

  1.02%

• Morgan Stanley - Brokerage Accounts

  0.36%

• Envestnet Asset Management Inc

  0.27%

• Susquehanna International Group, LLP

  0.26%

• Values First Advisors Inc

  0.25%

biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'​in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m